Get 40% Off
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Nu Skin Down 12% In 3 Months, Mainland China Is A Concern

Published 09/08/2019, 09:57 PM
Updated 07/09/2023, 06:31 AM
US500
-
EL
-
IPAR
-
NUS
-

Volatile business conditions in Mainland China along with an unimpressive view for 2019 are tarnishing Nu Skin Enterprises, Inc.’s (NYSE:NUS) image among investors. This zacks Rank #4 (Sell) stock lost nearly 12.1% in the past three months compared with the industry’s rise of 9.4%. Let’s take a closer look at the aspects ailing this renowned cosmetics player.



Sluggish Sales in Mainland China is a Concern

Nu Skin faced hurdles in Mainland China during the second quarter of 2019, thanks to the government’s 100-day campaign to inspect offerings of direct selling and health products industries. The campaign resulted in adversities like limited sales meetings, media scrutiny and unfavorable consumer sentiments. As a result of such moves, revenues from the Mainland China region plunged as much as 24% in the second quarter. Such headwinds took a toll on the company’s top- and-bottom line performance in the said period.

Since Mainland China contributes a major portion to Nu Skin’s revenues, persistent hurdles in the region are likely to keep exerting pressure on the company’s performance in the forthcoming periods. In fact, setbacks in Mainland China have propelled management to trim 2019 guidance and provide unimpressive view for the third quarter.

Currency Related Headwinds

A major share of Nu Skin’s revenues is sourced from international markets, which exposes the company to significant currency risks. During the second quarter of 2019, the company’s top line was hurt by nearly 4% (or approximately $31 million) due to foreign-currency fluctuations. Currency headwinds have also dented gross margin in the quarter. During the first quarter, the top line was hurt by currency headwinds of approximately 6%. Moreover, management expects foreign currency fluctuations to affect the company’s revenues in 2019 by almost 3-4% and nearly 2% in the third quarter.

Efforts to Revive Performance

We note that the company is undertaking several initiatives to accelerate growth in Mainland China. In this context, the company is planning to launch an improved version of Galvanic Spa along with the new ageLOC Nutrial hair and scalp treatment system. Management also plans to roll out new incentives system for the region to enhance productivity of sales leaders. In addition to this, Nu Skin is on track with product development strategies and customer retention programs across all key market locations. In fact, it is striving to expand its sales compensation program — Velocity.

All said, lets wait and see if these measures can help the company to achieve a turnaround in the forthcoming periods.

Looking for Cosmetics Stocks? Check These

Helen of Troy (NYSE:EL) flaunts a Zacks Rank #1 (Strong Buy) and has long-term earnings per share (EPS) growth rate of 6.7%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Inter Parfums (NASDAQ:IPAR) presently has a Zacks Rank #2 (Buy) and long-term EPS growth rate of 12.5%.

The Estee Lauder Companies (NYSE:EL) currently has a long-term EPS growth rate of 13% and a Zacks Rank of 2.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.

This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.

See their latest picks free >>



The Estee Lauder Companies Inc. (EL): Free Stock Analysis Report

Inter Parfums, Inc. (IPAR): Free Stock Analysis Report

Helen of Troy Limited (HELE): Free Stock Analysis Report

Nu Skin Enterprises, Inc. (NUS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.